Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT05212103
What this trial is testing

PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9

Who this might be right for
Acute Myeloid LeukemiaMelanomaNon Small Cell Lung Cancer
Turku University Hospital 30
Not applicableStudy completedNCT02765061
What this trial is testing

Hyponatremia and Hypoalbuminemia is Morbimortality Predictors in Coronary Artery Bypass Graft Surgery

Who this might be right for
Coronary Artery DiseaseHyponatremiaHypoalbuminemia
Ankara University 1,157
Testing effectiveness (Phase 2)Active Not RecruitingNCT04497961
What this trial is testing

Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 95
Post-approval studies (Phase 4)Ended earlyNCT01147042
What this trial is testing

Biochemical Response to Interferon-Gamma in Subjects With Specific Gene Mutation in Chronic Granulomatous Disease

Who this might be right for
IFN-Gamma TherapyCGD Gene MutationCGD Response to IFNg+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 2
Not applicableStudy completedNCT01811342
What this trial is testing

Continuous Hemoglobin Evaluation

Who this might be right for
Anemia
University of California, Davis 70
Early research (Phase 1)Ended earlyNCT04480086
What this trial is testing

Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis

Who this might be right for
Myelofibrosis (MF)
AbbVie 1
Early research (Phase 1)WithdrawnNCT07428486
What this trial is testing

FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Phase IFLAG ChemotherapyLisaftoclax+3 more
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Study completedNCT02246868
What this trial is testing

An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients.

Who this might be right for
Haemophilia A
Bio Products Laboratory
Testing effectiveness (Phase 2)Study completedNCT00006890
What this trial is testing

Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
NCIC Clinical Trials Group 67
Early research (Phase 1)Study completedNCT00410982
What this trial is testing

Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies

Who this might be right for
LeukemiaLymphomaMyeloma
M.D. Anderson Cancer Center 145
Early research (Phase 1)Study completedNCT01713582
What this trial is testing

A Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/ Birabresib (MK-8628) in Hematologic Malignancies (MK-8628-001)

Who this might be right for
Acute Myeloid LeukemiaDiffuse Large B-cell LymphomaAcute Lymphoblastic Leukemia+1 more
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 141
Large-scale testing (Phase 3)Active Not RecruitingNCT05135559
What this trial is testing

A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors

Who this might be right for
Haemophilia A and B With and Without Inhibitors
Novo Nordisk A/S 153
Testing effectiveness (Phase 2)Study completedNCT03439280
What this trial is testing

Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM)

Who this might be right for
Relapsed/RefractoryMultiple Myeloma
Millennium Pharmaceuticals, Inc. 50
Large-scale testing (Phase 3)UnknownNCT01619046
What this trial is testing

Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A

Who this might be right for
Hemophilia A
Green Cross Corporation 124
Not applicableUnknownNCT03592303
What this trial is testing

Bedside Assessment of Coagulation in Post-partum Hemorrhage by Thromboelastography (TEG ®6S)

Who this might be right for
Coagulation Defect; PuerperalPost Partum HemorrhageBlood Protein Disorders+1 more
Assistance Publique - Hôpitaux de Paris 100
Testing effectiveness (Phase 2)WithdrawnNCT00002761
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Columbia University
Not applicableStudy completedNCT02627261
What this trial is testing

Multiple Myeloma Minimal Residual Disease

Who this might be right for
Multiple Myeloma
Hospices Civils de Lyon 48
Testing effectiveness (Phase 2)Ended earlyNCT01102218
What this trial is testing

A Safety Study of Pentoxifylline for the Treatment of Anemia

Who this might be right for
End Stage Renal Disease
Fresenius Medical Care North America 48
Not applicableStudy completedNCT03383913
What this trial is testing

HRV-B for Symptom Management in Sickle Cell Patients

Who this might be right for
Sickle Cell Disease
Prisma Health-Upstate 15
Large-scale testing (Phase 3)UnknownNCT03947320
What this trial is testing

Safety,Efficacy and Pharmacokinetics Evaluation of SCT800 in Previously Treated Paediatric Patients With Severe Haemophilia A.

Who this might be right for
Hemophilia A
Sinocelltech Ltd. 70
Next Page